Loading... Please wait...

Sort by:

Cancer

  • biomarker report
    $2,500.00 Choose Options Biomarker Technology Platforms for Cancer Diagnoses and Therapies
    Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis. In the major solid cancer...
  • breast cancer therapies report
    $2,500.00 Choose Options Breast Cancer Therapies Markets
    Breast cancer therapies are entering a new era as game-changers emerge for each of the major breast cancer patient populations. New market entrants must possess drug profiles and a savvy clinical development program to...
  • cancer cell therapy report
    $2,500.00 Choose Options Cancer Cell Therapy Markets
    Traditionally, treatment of disease is carried out by small molecules that target specific cell types. In diseases such as cancer, the treatment is meant to kill cancer cells, leading to the removal or at least the...
  • cancer diagnostic report
    $5,500.00 Choose Options Cancer Diagnostic Testing World Markets
    Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment. The National Cancer Institute estimates that about ten million Americans have or have had some...
  • cancer reports
    $24,225.00 Choose Options Cancer Reports Bundle
    The Cancer Reports Bundle includes the following TriMark Publications reports at a 15% discount off the individual reports being purchased separately:   - Biomarker Technology Platforms for Cancer Diagnoses and...
  • cancer therapeutics report
    $2,500.00 Choose Options Cancer Therapeutics Markets
    Cancer is the second leading cause of death by disease in the United States, exceeded only by heart disease. Traditionally cancer has been treated with surgery, chemotherapy, hormones and radiation therapy, alone or in...
  • cancer vaccines report
    $2,500.00 Choose Options Cancer Vaccines Markets
    Cancer vaccines have the potential to become a significant force in future cancer treatments. In 2010, Dendreon's Provenge became the first cancer vaccine approved by the FDA, generating renewed interest and support for this...
  • personalized medicine cancer report
    $4,000.00 Choose Options Companion Diagnostics in Personalized Medicine and Cancer Therapy
    Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy. This linkage could be important in the therapeutic application and...
  • cytology report
    $2,500.00 Choose Options Cytology and HPV Testing World Markets
    Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. If the spread is not controlled, it can result in death. Cancer is caused by both external (chemicals, radiation and viruses)...
  • mammography report
    $2,500.00 Choose Options Mammography World Markets
    Breast cancer is the most common type of cancer in women, affecting one in eight during their lives. Mammography is the most valuable method for detecting potentially cancerous anomalies in the breast. As such, the...
  • molecular diagnostics cancer report
    $5,500.00 Choose Options Molecular Diagnostics in Cancer Testing
    Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umbrella of molecular diagnostics include...